Buprenorfina : opioid o unikalnych właściwościach

2016
journal article
review article
dc.abstract.enOpioid analgesics are the basis for the treatment of moderate and severe pain, regardless of its etiology. Opioids used in clinical practice differ significantly in terms of pharmacological properties.The differences allowto adjust individual medicine, what increases both the effectiveness and the safety of treatment. Buprenorphine is an opioid analgesic with special properties that are still not fully understood. The medicine is widely used to treat both acute and chronic pain, both in non-cancer pain and cancer patients, also as a substitution therapy for drug addicts. A unique, different from other opioids, pharmacological and clinical profile of buprenorphine has been demonstrated in numerous experimental and clinical studies, conducted in various chronic pain syndromes. The most important clinical aspects relate to the safety profile of buprenorphine and include ceiling effect for respiratory depression, low risk of constipation, less effect on the CNS in comparison to other strong opioids, little or no immunosuppressive effect, inhibition of hyperalgesia, no accumulation in renal impairment, and minimal risk of drug-drug interactions. These aspects make buprenorphine valuable therapeutic option in chronic pain treatment. In the paper the authors discuss the most relevant aspects for clinician: pharmacodynamics, pharmacokinetics, safety profile of buprenorphine and its effectiveness in the variety of chronic pain syndromes and in other chronic diseases.pl
dc.affiliationWydział Lekarski : Zakład Badania i Leczenia Bólupl
dc.cm.date2020-01-07
dc.cm.id81207
dc.contributor.authorKocot-Kępska, Magdalena - 241947 pl
dc.contributor.authorPrzeklasa-Muszyńska, Anna - 133224 pl
dc.contributor.authorDobrogowski, Jan - 129185 pl
dc.date.accession2021-01-04pl
dc.date.accessioned2020-01-17T09:14:29Z
dc.date.available2020-01-17T09:14:29Z
dc.date.issued2016pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.additionalBibliogr. s. 86-88, streszcz. w jęz. pol.pl
dc.description.number3pl
dc.description.physical77-88pl
dc.description.points6pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume10pl
dc.identifier.eissn1689-4898
dc.identifier.issn1898-0678pl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/139998
dc.identifier.weblinkhttps://journals.viamedica.pl/palliative_medicine_in_practice/article/view/48219pl
dc.languagepolpl
dc.language.containerpolpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC-ND
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subject.enbuprenorphinepl
dc.subject.enchronic painpl
dc.subject.enpharmacotherapypl
dc.subject.enopioidspl
dc.subject.plbuprenorfinapl
dc.subject.plból przewlekłypl
dc.subject.plfarmakoterapiapl
dc.subject.plopioidypl
dc.subtypeReviewArticlepl
dc.titleBuprenorfina : opioid o unikalnych właściwościachpl
dc.title.alternativeBuprenorphine : opioid with unique propertiespl
dc.title.journalMedycyna Paliatywna w Praktycepl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.abstract.enpl
Opioid analgesics are the basis for the treatment of moderate and severe pain, regardless of its etiology. Opioids used in clinical practice differ significantly in terms of pharmacological properties.The differences allowto adjust individual medicine, what increases both the effectiveness and the safety of treatment. Buprenorphine is an opioid analgesic with special properties that are still not fully understood. The medicine is widely used to treat both acute and chronic pain, both in non-cancer pain and cancer patients, also as a substitution therapy for drug addicts. A unique, different from other opioids, pharmacological and clinical profile of buprenorphine has been demonstrated in numerous experimental and clinical studies, conducted in various chronic pain syndromes. The most important clinical aspects relate to the safety profile of buprenorphine and include ceiling effect for respiratory depression, low risk of constipation, less effect on the CNS in comparison to other strong opioids, little or no immunosuppressive effect, inhibition of hyperalgesia, no accumulation in renal impairment, and minimal risk of drug-drug interactions. These aspects make buprenorphine valuable therapeutic option in chronic pain treatment. In the paper the authors discuss the most relevant aspects for clinician: pharmacodynamics, pharmacokinetics, safety profile of buprenorphine and its effectiveness in the variety of chronic pain syndromes and in other chronic diseases.
dc.affiliationpl
Wydział Lekarski : Zakład Badania i Leczenia Bólu
dc.cm.date
2020-01-07
dc.cm.id
81207
dc.contributor.authorpl
Kocot-Kępska, Magdalena - 241947
dc.contributor.authorpl
Przeklasa-Muszyńska, Anna - 133224
dc.contributor.authorpl
Dobrogowski, Jan - 129185
dc.date.accessionpl
2021-01-04
dc.date.accessioned
2020-01-17T09:14:29Z
dc.date.available
2020-01-17T09:14:29Z
dc.date.issuedpl
2016
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.additionalpl
Bibliogr. s. 86-88, streszcz. w jęz. pol.
dc.description.numberpl
3
dc.description.physicalpl
77-88
dc.description.pointspl
6
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
10
dc.identifier.eissn
1689-4898
dc.identifier.issnpl
1898-0678
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/139998
dc.identifier.weblinkpl
https://journals.viamedica.pl/palliative_medicine_in_practice/article/view/48219
dc.languagepl
pol
dc.language.containerpl
pol
dc.rights*
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa
dc.rights.licence
CC-BY-NC-ND
dc.rights.uri*
http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subject.enpl
buprenorphine
dc.subject.enpl
chronic pain
dc.subject.enpl
pharmacotherapy
dc.subject.enpl
opioids
dc.subject.plpl
buprenorfina
dc.subject.plpl
ból przewlekły
dc.subject.plpl
farmakoterapia
dc.subject.plpl
opioidy
dc.subtypepl
ReviewArticle
dc.titlepl
Buprenorfina : opioid o unikalnych właściwościach
dc.title.alternativepl
Buprenorphine : opioid with unique properties
dc.title.journalpl
Medycyna Paliatywna w Praktyce
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
136
Views per month
Views per city
Warsaw
32
Krakow
11
Katowice
9
Poznan
9
Gdansk
7
Wroclaw
7
Lublin
4
Monterrey
3
Biała Podlaska
2
Chorzów
2
Downloads
kocot-kepska_et-al_opioid_o_unikalnych_wlasciwosciach_2016.pdf
43
kocot-kepska_et-al_opioid_o_unikalnych_wlasciwosciach_2016.odt
5